Abstract

BackgroundHospitalization of cancer patients is associated with poor overall survival, but prognostic misclassification may lead to suboptimal therapeutic decisions and transitions of care. No model is currently available for stratifying the heterogeneous population of oncological patients after a hospital admission to a general Medical Oncology ward. We developed a multivariable prognostic model based on readily available and objective clinical data to estimate survival in oncological patients after hospital discharge.MethodsA multivariable model and nomogram for overall survival after hospital discharge was developed in a retrospective training cohort and prospectively validated in an independent set of adult patients with solid tumors and a first admission to a unit of medical oncology. Performance of the model was assessed by C-index and Kaplan–Meier survival curves stratified by risk categories.ResultsFrom a population of 1089 patients with a first hospitalization, 757 patients were included in the training group [median survival, 43 weeks; 95% confidence interval (CI), 37-51 weeks] and 200 patients in the validation cohort (median survival, 44 weeks; 95% CI, 34 weeks-not reached). An accelerated failure time log-normal model was built, including five variables (primary tumor, stage, cause of admission, active treatment, and age). The C-index was 0.71 (95% CI, 0.69-0.73), with a good calibration, and adequate validation in the prospective cohort (C-index: 0.69; 95% CI, 0.65-0.74). Median survival in three predefined model-based risk groups was 10.7 weeks (high), 27.0 weeks (intermediate), and 3 years (low) in the training cohort, with comparable values in the validation cohort.ConclusionsIn oncological patients, individualized predictions of survival after hospitalization were provided by a simple and validated model. Further evaluation of the model might determine whether its use improves shared decision making at discharge.

Highlights

  • Admission to hospital is a negative prognostic factor for oncological patients

  • The study population (757 patients included in the training group and the 200 patients included in the validation cohort) was selected from a population of 1089 patients with a first hospitalization in a Medical Oncology unit of a single Spanish public hospital

  • Median overall survival (OS) after discharge was similar for both cohorts: weeks in the training group, versus weeks [95% confidence interval (CI): 34 weeks-not reached (NR)] among patients from the prospective validation cohort (Supplementary Figure S2, available at https://doi.org/10. 1016/j.esmoop.2022.100384)

Read more

Summary

Introduction

Admission to hospital is a negative prognostic factor for oncological patients. Regardless of the cause of admission, a median overall survival (OS) of w5 months is reported in some studies.[1]. Providing physicians with better prognostic stratification tools at time of discharge might improve patient care after hospitalization and avoid overtreatment of patients with a limited life expectancy. Hospitalization of cancer patients is associated with poor overall survival, but prognostic misclassification may lead to suboptimal therapeutic decisions and transitions of care. No model is currently available for stratifying the heterogeneous population of oncological patients after a hospital admission to a general Medical Oncology ward. We developed a multivariable prognostic model based on readily available and objective clinical data to estimate survival in oncological patients after hospital discharge. Methods: A multivariable model and nomogram for overall survival after hospital discharge was developed in a retrospective training cohort and prospectively validated in an independent set of adult patients with solid tumors and a first admission to a unit of medical oncology.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call